Search

everythinglearnresearchcommunity

for

Search:↓

Perilla frutescens is a versatile herb with health benefits and potential in food and industrial uses.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

TLR4 is important in aging-related diseases and could be a new treatment target.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Nonhuman primates are valuable in research but their natural health variations can complicate study results.

COVID-19 may trigger sudden temporary hair loss.

Engineered skin tissue is a promising tool for safer cosmetic testing.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

Kawasaki's disease can occur in adults and should be considered with specific symptoms and high ferritin levels.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

The gel with coral extract and pectin nanoparticles helps heal chronic wounds.

Microneedles improve drug delivery, patient compliance, and have potential in cancer treatment and skin care.

Cannabis has anti-inflammatory and antimicrobial properties, but more research is needed on its effects on plant and aquatic animal pathogens.

We need safe, affordable drugs to fight coronaviruses effectively.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Cepharanthine shows promise as a COVID-19 treatment.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

The machine learning model accurately detected hair loss and scalp diseases using processed images.

Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.

Lupeol shows promise for hair growth but needs better absorption and safety testing.